DP facility at Chicago for Vial & PFS
DP expansion facility at New Jersey
State of art, qualified PFS filling line from Optima pharma GmbH
Aseptic Fill-Finish Operation using SUT.
Annual capabilities of > 6.5 Million units.
State of art biochemical, and microbiology laboratory
Capable of inhouse release and stability testing of DS, DP, process related, protein related impurities & in vitro bioassay.
Secondary packaging capability along with Syringe Labeling, Plunger and Safety Device assembly and serialization